Home/Pipeline/REMOXY (oxycodone) ER

REMOXY (oxycodone) ER

Chronic Pain

NDA ResubmittedActive

Key Facts

Indication

Chronic Pain

Phase

NDA Resubmitted

Status

Active

Company

Jubilant Pharmova

About Jubilant Pharmova

Jubilant Pharmova's mission is to become a leading global pharmaceutical company by delivering high-quality, affordable medicines through innovation and operational excellence. The company has achieved this through strategic vertical integration, building world-class manufacturing assets for complex APIs and sterile injectables, and establishing a strong global footprint. Its core strategy focuses on deepening capabilities in high-growth specialty segments like oncology and radiopharmaceuticals, while expanding its high-margin Contract Development and Manufacturing (CDMO) business to leverage global outsourcing trends.

View full company profile

Therapeutic Areas

Oncology Central Nervous System Allergy/Immunology Infectious Disease Cardiovascular Pain Management

Other Chronic Pain Drugs

Drug	Company	Phase	Status
SCI-160	SciSparc	Preclinical	Active
Injectrode Platform for Chronic Pain	Neuronoff	Pre-clinical	Active
Novel PNS System	Nervonik	First-in-Human Completed	Active
Pain Pipeline	Centrexion Therapeutics	Clinical Stage	Active
High-Definition Spinal Cord Stimulation	Micro-Leads	Unknown	Active
Precision Medicine for Pain	MindX Sciences	Commercial	Active
Chronic Pain Program	Current Surgical	Research	Active
N-19a	Neurocarrus	Pre-clinical	Active
Nav1.7 ASO	Quiver Bioscience	Discovery	Active
Nav1.8 ASO	Quiver Bioscience	Discovery	Active
Dual Nav1.7/1.8 ASO	Quiver Bioscience	Discovery	Active
TMS for Chronic Pain	Magstim	Commercial/Clinical Development	Active